Overcoming mRNA Process Challenges
Scott Ripley
For mRNA technology to reach its full potential, innovations in manufacturing are needed
Scott Ripley
Scott Ripley is the general manager of the nucleic acid therapeutics business for Cytiva, leading the global commercial go-to-market strategy. Scott has more than 20 years of experience across research and bioprocess businesses, including a recent focus on the mRNA domain.